Breast Cancer Chemoprevention – a vital yet underused treatment modality

Share this article

Dr. Muhammad N. Siddique is one of the most highly qualified Oncologists in Lahore.

Oncologists in Lahore

Number of Breast cancer screenings has seen a significant rise in Lahore during the last few years – thanks to rigorous awareness campaigns and highly trained Oncologists in Lahore. This has certainly led to a greater proportion of patients diagnosed at an early stage hopefully translating into an enhanced survival of breast cancer patients. However, it seems breast cancer chemoprevention remains relatively unemphasized and ignored even by physicians treating breast cancer on a daily basis. According to a US study, about 15 % of women above the age of 35 years were noted to be eligible for breast cancer chemoprevention. The primary objective of this manuscript is to sensitize the non-oncology health care provider regarding the importance of this valuable treatment strategy. Though a few and far between, those who may qualify for this strategy need to be identified.  

(more…)

Continue Reading Breast Cancer Chemoprevention – a vital yet underused treatment modality

Cancer Immunotherapy: What the non-oncology physicians need to know?

Share this article

Dr. Muhammad N. Siddique is one of the most highly qualified cancer doctors in Lahore.

T-Cell attacking a malignant cell

Until about 10 years ago, chemotherapy was the only meaningful option to treat most advanced malignancies. In the past two decades, rigorous research work has expanded treatment options by bringing forth immunotherapy and targeted therapy. Nivolumab was the first approved check point inhibitor (a form of immunotherapy), by US FDA in 2011. Its approval was granted for use in metastatic melanoma, for which really no meaningful therapy existed prior to that. Soon afterwards new drugs were developed. Cooperative research groups worked globally and with the help of collaborative trials very soon immunotherapy was confirmed to be useful in multiple other malignancies. Now, it is in widespread use for lung cancers, skin cancers, GI cancers, head and neck cancers, brain tumors, GU cancers, breast cancers, lymphoma, GYN malignancies etc.

(more…)

Continue Reading Cancer Immunotherapy: What the non-oncology physicians need to know?